Note: Ingredients listed on restricted chemical lists
EC/CAS
232-674-9/9004-34-6
Name of the chemical
cellulose
Concentration
N/A
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
022-006-
General Information
Revision date
2022-04-26
Product name
KRINTAFEL (TAFENOQUINE) 150MG TABLETS
Product Synonyms
TAFENOQUINE FILM-COATED TABLET * TAFENOQUINE [150MG] FILM-COATED TABLET *
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H372, H400, H410
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Acute toxicity, oral Category 4 H302 - Harmful if swallowed. Specific target organ toxicity - repeated Category 1 H372 - Causes damage to organs exposure through prolonged or repeated exposure.
Environmental hazards
Hazardous to the aquatic environment, acute Category 1 H400 - Very toxic to aquatic life. aquatic hazard Hazardous to the aquatic environment, Category 1 H410 - Very toxic to aquatic life long-term aquatic hazard with long lasting effects.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
HYDROXYPROPYL METHYL CELLULOSE, MICROCRYSTALLINE CELLULOSE, TAFENOQUINE, Titanium dioxide TAFENOQUINE. May produce an allergic reaction
Signal word
Danger
Hazard statements
H302 Harmful if swallowed. H372 Causes damage to organs through prolonged or repeated exposure. H400 Very toxic to aquatic life. H410 Very toxic to aquatic life with long lasting effects.
Prevention
P260 Do not breathe dust. P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P273 Avoid release to the environment.
Response
P330 Rinse mouth. P314 Get medical advice/attention if you feel unwell. P391 Collect spillage.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
57,8 % of the mixture consists of component(s) of unknown acute oral toxicity. 81,4125 % of the mixture consists of component(s) of unknown acute dermal toxicity. 81,4125 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 61,1125 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 61,1125 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. EUH208 -
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
